eClinicalソリューション市場:臨床試験フェーズ別、製品別(CDMS、EDC、CTMS、eCOA、RTSM、ETMF、分析、統合、安全性)、提供形態別(Webベース、オンデマンド、オンプレミス、クラウド)、エンドユーザー別(製薬・バイオ、病院、CRO) - 2026年までの世界予測eClinical Solutions Market by Clinical trial phases, Product (CDMS, EDC, CTMS, eCOA, RTSM, ETMF, Analytics, Integration, Safety), Delivery (Web-based, On demand, On premise, Cloud), End user (Pharma & Biotech, Hospitals, CROs) - Global Forecasts to 2026 eクリニカルソリューションの世界市場は、2021年の83億米ドルから2026年までに154億米ドルに達すると予測されており、年平均成長率は13.3%となっています。臨床研究に関連する運用コストや規制要件の増加、臨床試... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリーeクリニカルソリューションの世界市場は、2021年の83億米ドルから2026年までに154億米ドルに達すると予測されており、年平均成長率は13.3%となっています。臨床研究に関連する運用コストや規制要件の増加、臨床試験を支援するための政府助成金、製薬・バイオテクノロジー企業による医薬品開発のための研究開発費の増加などが、世界のeClinicalソリューション市場の主な推進要因となっています。クラウドベース(SaaS)セグメントが最も高いCAGRを記録すると予測される 世界のeClinicalソリューション市場は、提供形態に基づいて、ウェブホスト型(オンデマンド)、ライセンス型企業(オンプレミス)、クラウドベース(SaaS)のソリューションに分類されます。2020年には、ウェブホスティング(オンデマンド)セグメントが世界のeClinicalソリューション市場で最大のシェアを占めました。クラウドベースの臨床試験ソリューションの数が増加していることと、臨床研究におけるこれらのソリューションの採用が増えていること(統合が容易で、迅速な展開が可能で、固定の月額料金で柔軟な拡張性が得られるなどの利点があるため)が、クラウドベースのeClinicalソリューション市場の成長を促進しています。 予測期間中、第3相臨床試験が最も高い成長を示すと予想される 臨床試験のフェーズに基づいて、eClinicalソリューション市場は第I相試験、第II相試験、第III相試験、第IV相試験に分類されています。2020年のeClinicalソリューション市場では、第III相臨床試験のセグメントが最大のシェアを占めています。このセグメントの大きなシェアは、第III相臨床試験では数千人の患者が関与するため、eClinicalソリューションの需要が高いことに起因しています。 CROセグメントは、予測期間中に最も高いCAGRを記録すると推定されます。 エンドユーザー別に見ると、世界のeClinicalソリューション市場は、製薬・バイオ製薬企業、医薬品開発業務受託機関、コンサルティングサービス企業、医療機器メーカー、病院、学術研究機関に分類されます。2020年のeClinicalソリューション市場では、製薬会社・バイオ製薬会社セグメントが最大のシェアを占めています。しかし、CROセグメントは、今後5年間で最も高いCAGR(15.5%)を記録すると予測されます。先進国だけでなく発展途上国でもCROの数が増えていることや、専門の臨床研究機関に臨床試験を委託する事例が増えていることが、このセグメントの高い成長率の原因となっています。 北米は2021年から2026年にかけて大きな成長を遂げる この地域では、臨床試験を支援する政府補助金の増加、eClinicalソリューションベンダーによる継続的な製品開発と新製品の発売、新薬開発のための提携数の増加などが、eClinicalソリューションの需要をさらに刺激しています。 供給側一次インタビューの内訳- 企業タイプ別。企業タイプ別:Tier1 - 33%、Tier2 - 42%、Tier3 - 18% - 意欲別。Cレベル - 29%, ディレクターレベル - 23%, その他 - 48% - 地域別。北米 - 35%、欧州 - 30%、APAC - 26%、その他の地域 - 9 この市場の著名な企業としては、オラクルコーポレーション(米国)、メディデータ・ソリューションズ Inc.(米国)、Parexel International Corporation (米国)、BioClinica, Inc.(米国)、Signant Health (米国)、Datatrak International, Inc.(米国)、ERT(米国)、eClinical Solutions, Inc.(米国)、MaxisIT Inc.(米国)、Bio-Optronics, Inc.(米国)、Merge Healthcare Incorporated(米国)、OmniComm Systems, Inc.(米国) 調査範囲 本レポートでは、製品、提供形態、臨床試験のフェーズ、エンドユーザー、地域に基づいて、eClinical Solutions市場を説明・調査しています。この市場の成長に影響を与える主な要因と、市場力学に影響を与える要因に関する詳細な情報を提供しています。本レポートには、この市場における著名な企業の詳細な競合分析と製品マトリックスが含まれており、企業プロフィール、製品ポートフォリオ、最近の開発状況(合併、買収、パートナーシップ、協力関係など)、主要な事業戦略などが記載されています。 このレポートを購入する主なメリット 本レポートでは、様々なレベルの分析-業界動向、トッププレイヤーの市場シェア、企業プロファイルに焦点を当て、これらを合わせて基本的な見解を形成し、競合環境、高成長地域とそのドライバー、抑制、課題、機会を分析しています。本レポートは、既存の企業だけでなく、新規参入者や小規模な企業が市場の動向を把握し、より大きなシェアを獲得するために役立ちます。
SummaryThe global eClinical Solutions market is projected to reach USD 15.4 billionby 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech companies are some of the major driving factors for the global eClinical solutions market. Table of Contents
1 INTRODUCTION 33
1.1 OBJECTIVES OF THE STUDY 33
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 34
1.2.2 MARKETS COVERED 35
1.2.3 GEOGRAPHIC SCOPE 35
1.2.4 YEARS CONSIDERED FOR THE STUDY 36
1.3 CURRENCY 36
1.4 LIMITATIONS 36
1.5 MAJOR MARKET STAKEHOLDERS 37
1.6 SUMMARY OF CHANGES 37
2 RESEARCH METHODOLOGY 38
2.1 RESEARCH APPROACH 38
2.2 RESEARCH METHODOLOGY DESIGN 38
FIGURE 1 ECLINICAL SOLUTIONS MARKET: RESEARCH DESIGN 38
2.2.1 SECONDARY RESEARCH 39
2.2.1.1 Key data from secondary sources 39
2.2.2 PRIMARY DATA 40
FIGURE 2 PRIMARY SOURCES 40
2.2.2.1 Key data from primary sources 41
2.2.2.2 Insights from primary experts 42
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS:
BY COMPANY, DESIGNATION, AND REGION 43
2.3 MARKET SIZE ESTIMATION: ECLINICAL SOLUTIONS MARKET 43
FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 44
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION 44
FIGURE 6 REVENUE ANALYSIS OF TOP 3 PUBLIC COMPANIES:
ECLINICAL SOLUTIONS MARKET (2020) 45
FIGURE 7 BOTTOM-UP APPROACH 46
FIGURE 8 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF ECLINICAL
SOLUTIONS MARKET (2021–2026) 47
FIGURE 9 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 48
FIGURE 10 TOP-DOWN APPROACH 48
2.4 MARKET BREAKDOWN & DATA TRIANGULATION 49
FIGURE 11 DATA TRIANGULATION METHODOLOGY 49
2.5 MARKET SHARE ESTIMATION 50
2.6 ASSUMPTIONS FOR THE STUDY 50
2.7 LIMITATIONS 50
2.7.1 METHODOLOGY-RELATED LIMITATIONS 50
2.7.2 SCOPE-RELATED LIMITATIONS 51
2.8 RISK ASSESSMENT 51
TABLE 1 RISK ASSESSMENT: ECLINICAL SOLUTIONS MARKET 51
3 EXECUTIVE SUMMARY 52
FIGURE 12 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2021 VS. 2026 (USD MILLION) 53
FIGURE 13 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2021 VS. 2026 (USD MILLION) 54
FIGURE 14 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2021 VS. 2026 (USD MILLION) 54
FIGURE 15 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2021 VS. 2026 (USD MILLION) 55
FIGURE 16 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2020 (USD MILLION) 56
4 PREMIUM INSIGHTS 57
4.1 ECLINICAL SOLUTIONS: MARKET OVERVIEW 57
FIGURE 17 EMERGING COUNTRIES OFFER HIGH GROWTH OPPORTUNITIES DURING FORECAST PERIOD 57
4.2 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET,
BY DELIVERY MODE AND COUNTRY (2020) 58
FIGURE 18 WEB-HOSTED DELIVERY MODE DOMINATED ECLINICAL
SOLUTIONS MARKET IN 2020 58
4.3 ECLINICAL SOLUTIONS MARKET SHARE, BY CLINICAL TRIAL PHASE (2021 VS. 2026) 58
FIGURE 19 PHASE III CLINICAL TRIALS TO DOMINATE GLOBAL ECLINICAL SOLUTIONS MARKET DURING FORECAST PERIOD 58
5 MARKET OVERVIEW 59
5.1 INTRODUCTION 59
5.2 MARKET DYNAMICS 59
FIGURE 20 GLOBAL ECLINICAL SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 59
5.2.1 MAJOR MARKET DRIVERS 60
5.2.1.1 Increasing operational costs and regulatory requirements associated with clinical research studies 60
5.2.1.2 Growing adoption of novel software solutions in clinical research 60
5.2.1.3 Increased government funding and grants to support clinical trials 61
5.2.1.4 Need for improved data standardization 61
5.2.1.5 Increasing R&D expenditure on drug development pipeline by pharma-biotech companies 62
5.2.1.6 Growing customer base for eClinical solutions 62
TABLE 2 US: INDICATIVE LIST OF LIFE SCIENCE STARTUPS LAUNCHED
BETWEEN 2011 & 2015 63
5.2.2 MAJOR MARKET RESTRAINTS 63
5.2.2.1 High implementation costs associated with eClinical solutions 63
5.2.2.2 Dearth of skilled professionals to operate eClinical solutions 63
5.2.2.3 Limited awareness of advantages of eClinical solutions among researchers 64
5.2.3 KEY GROWTH OPPORTUNITIES 64
5.2.3.1 Increasing clinical research activities in emerging Asian countries 64
5.2.3.2 Greater outsourcing of clinical trial processes to CROs 64
5.2.3.3 Rising number of clinical trials in emerging countries 64
5.2.3.4 Shift from manual data interpretation to real-time data analysis during clinical studies 65
5.2.4 MAJOR MARKET CHALLENGES 65
5.2.4.1 Limited adoption of eClinical solutions in developing nations 65
5.2.4.2 Concerns about software reliability 65
5.2.4.3 Patient privacy issues 66
5.3 IMPACT OF COVID-19 ON THE ECLINICAL SOLUTIONS MARKET 66
5.4 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET 67
FIGURE 21 ECOSYSTEM ANALYSIS OF ECLINICAL SOLUTIONS MARKET 67
5.5 CASE STUDIES 67
5.5.1 YORK TEACHING HOSPITAL SPEEDS UP DATA CAPTURE PROCESS DURING PHASE III CLINICAL STUDY 67
5.5.2 LSHTM AND MENAFRICAR USE DATA CAPTURE SOFTWARE TO STUDY MENINGOCOCCAL CARRIAGE IN AFRICAN MENINGITIS BELT 67
5.5.3 CLINICAL TRIALS GROUP AT UCL USES EDC SYSTEM TO
CAPTURE AND VERIFY PATIENT FEEDBACK 68
5.6 VALUE CHAIN ANALYSIS 68
FIGURE 22 ECLINICAL SOLUTIONS : VALUE CHAIN 68
5.7 PORTER’S FIVE FORCES ANALYSIS 68
TABLE 3 HIGH CAPITAL INVESTMENTS TO RESTRICT ENTRY OF NEW PLAYERS 68
5.7.1 THREAT OF NEW ENTRANTS 69
5.7.2 THREAT OF SUBSTITUTES 69
5.7.3 BARGAINING POWER OF BUYERS 69
5.7.4 BARGAINING POWER OF SUPPLIERS 69
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 69
6 GLOBAL ECLINICAL SOLUTIONS MARKET, BY PRODUCT 70
6.1 INTRODUCTION 71
TABLE 4 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 71
TABLE 5 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 72
6.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 72
TABLE 6 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 73
TABLE 7 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION) 73
TABLE 8 GLOBAL ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 73
TABLE 9 NORTH AMERICA: ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 74
6.3 CLINICAL TRIAL MANAGEMENT SYSTEMS 74
TABLE 10 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 75
TABLE 11 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION) 75
TABLE 12 GLOBAL CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 75
TABLE 13 NORTH AMERICA: CLINICAL TRIAL MANAGEMENT SYSTEMS MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION) 76
6.4 CLINICAL ANALYTICS PLATFORMS 76
TABLE 14 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 77
TABLE 15 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION) 77
TABLE 16 GLOBAL CLINICAL ANALYTICS PLATFORMS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 77
TABLE 17 NORTH AMERICA: CLINICAL ANALYTICS PLATFORMS MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION) 78
6.5 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 78
TABLE 18 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 78
TABLE 19 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION) 79
TABLE 20 GLOBAL RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 79
TABLE 21 NORTH AMERICA: RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 79
6.6 CLINICAL DATA INTEGRATION PLATFORMS 79
TABLE 22 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY REGION, 2015–2018 (USD MILLION) 80
TABLE 23 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION) 80
TABLE 24 GLOBAL CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION) 81
TABLE 25 NORTH AMERICA: CLINICAL DATA INTEGRATION PLATFORMS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 81
6.7 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 81
TABLE 26 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 82
TABLE 27 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION) 82
TABLE 28 GLOBAL ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 82
TABLE 29 NORTH AMERICA: ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 83
6.8 SAFETY SOLUTIONS 83
TABLE 30 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 83
TABLE 31 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION) 84
TABLE 32 GLOBAL SAFETY SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 84
TABLE 33 NORTH AMERICA: SAFETY SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 84
6.9 ELECTRONIC TRIAL MASTER FILE SYSTEMS 84
TABLE 34 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE,
BY REGION, 2015–2018 (USD MILLION) 85
TABLE 35 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE,
BY COUNTRY, 2015–2018 (USD MILLION) 85
TABLE 36 GLOBAL ELECTRONIC TRIAL MASTER FILE SYSTEMS MARKET SIZE,
BY REGION, 2019–2026 (USD MILLION) 85
TABLE 37 NORTH AMERICA: ELECTRONIC TRIAL MASTER FILE MARKET SIZE,
BY COUNTRY, 2019–2026 (USD MILLION) 86
6.10 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 86
TABLE 38 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 86
TABLE 39 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE ,BY COUNTRY, 2015–2018 (USD MILLION) 87
TABLE 40 GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 87
TABLE 41 NORTH AMERICA: GLOBAL REGULATORY INFORMATION MANAGEMENT SOLUTIONS (RIMS) MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 87
6.11 OTHER ECLINICAL SOLUTIONS 88
TABLE 42 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 88
TABLE 43 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2015–2018 (USD MILLION) 88
TABLE 44 GLOBAL OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 89
TABLE 45 NORTH AMERICA: OTHER ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2019–2026 (USD MILLION) 89
7 ECLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 90
7.1 INTRODUCTION 91
TABLE 46 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2015–2018 (USD MILLION) 91
TABLE 47 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY MODE OF DELIVERY, 2019–2026 (USD MILLION) 91
7.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 91
TABLE 48 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 92
TABLE 49 WEB-HOSTED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 92
7.3 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 92
TABLE 50 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2015–2018 (USD MILLION) 93
TABLE 51 LICENSED ENTERPRISE ECLINICAL SOLUTIONS MARKET SIZE, BY REGION, 2019–2026 (USD MILLION) 93
7.4 CLOUD-BASED (SAAS) SOLUTIONS 94
TABLE 52 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 95
TABLE 53 CLOUD-BASED ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 95
8 GLOBAL ECLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 96
8.1 INTRODUCTION 97
FIGURE 23 PHASE III TRIALS SEGMENT TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 97
TABLE 54 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 97
TABLE 55 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 98
8.2 PHASE I CLINICAL TRIALS 98
TABLE 56 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION) 98
TABLE 57 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE I CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION) 99
8.3 PHASE II CLINICAL TRIALS 99
TABLE 58 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION) 100
TABLE 59 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE II CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION) 100
8.4 PHASE III CLINICAL TRIALS 100
TABLE 60 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION) 101
TABLE 61 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE III CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION) 101
8.5 PHASE IV CLINICAL TRIALS 102
TABLE 62 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS,
BY REGION, 2015–2018 (USD MILLION) 102
TABLE 63 ECLINICAL SOLUTIONS MARKET SIZE FOR PHASE IV CLINICAL TRIALS,
BY REGION, 2019–2026 (USD MILLION) 102
9 ECLINICAL SOLUTIONS MARKET, BY END USER 103
9.1 INTRODUCTION 104
FIGURE 24 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY END USER (2020) 104
TABLE 64 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 104
TABLE 65 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 105
9.2 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 105
TABLE 66 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2015–2018 (USD MILLION) 106
TABLE 67 ECLINICAL SOLUTIONS MARKET SIZE FOR PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, BY REGION, 2019–2026 (USD MILLION) 106
9.3 CONTRACT RESEARCH ORGANIZATIONS 106
TABLE 68 KEY STRATEGIC ALLIANCES BETWEEN CROS AND PHARMA COMPANIES (2011–2015) 107
TABLE 69 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2015–2018 (USD MILLION) 107
TABLE 70 ECLINICAL SOLUTIONS MARKET SIZE FOR CROS, BY REGION,
2019–2026 (USD MILLION) 108
9.4 CONSULTING SERVICE COMPANIES 108
TABLE 71 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2015–2018 (USD MILLION) 109
TABLE 72 ECLINICAL SOLUTIONS MARKET SIZE FOR CONSULTING SERVICE COMPANIES, BY REGION, 2019–2026 (USD MILLION) 109
9.5 MEDICAL DEVICE MANUFACTURERS 109
TABLE 73 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2015–2018 (USD MILLION) 110
TABLE 74 ECLINICAL SOLUTIONS MARKET SIZE FOR MEDICAL DEVICE MANUFACTURERS, BY REGION, 2019–2026 (USD MILLION) 110
9.6 HOSPITALS 110
TABLE 75 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2015–2018 (USD MILLION) 111
TABLE 76 ECLINICAL SOLUTIONS MARKET SIZE FOR HOSPITALS, BY REGION,
2019–2026 (USD MILLION) 111
9.7 ACADEMIC RESEARCH INSTITUTES 111
TABLE 77 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2018 (USD MILLION) 112
TABLE 78 ECLINICAL SOLUTIONS MARKET SIZE FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2019–2026 (USD MILLION) 112
10 ECLINICAL SOLUTIONS MARKET, BY REGION 113
10.1 INTRODUCTION 114
FIGURE 25 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2021 VS. 2026 (USD MILLION) 114
TABLE 79 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2015–2018 (USD MILLION) 115
TABLE 80 GLOBAL ECLINICAL SOLUTIONS MARKET SIZE, BY REGION,
2019–2026 (USD MILLION) 115
10.2 NORTH AMERICA 116
FIGURE 26 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SNAPSHOT 116
TABLE 81 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION) 117
TABLE 82 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 117
TABLE 83 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 117
TABLE 84 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 118
TABLE 85 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION) 118
TABLE 86 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION) 118
TABLE 87 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 119
TABLE 88 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 119
TABLE 89 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION) 119
TABLE 90 NORTH AMERICA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION) 120
10.2.1 US 120
10.2.1.1 Availability of government funding for clinical research to drive market growth 120
TABLE 91 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 121
TABLE 92 US: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 122
TABLE 93 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 122
TABLE 94 US: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 122
TABLE 95 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2018 (USD MILLION) 123
TABLE 96 US: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2019–2026 (USD MILLION) 123
TABLE 97 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 123
TABLE 98 US: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 124
10.2.2 CANADA 124
10.2.2.1 Government support to contribute to market growth 124
TABLE 99 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 125
TABLE 100 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 125
TABLE 101 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 126
TABLE 102 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 126
TABLE 103 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 126
TABLE 104 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 127
TABLE 105 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 127
TABLE 106 CANADA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 127
10.3 EUROPE 128
FIGURE 27 EUROPE: ECLINICAL SOLUTIONS MARKET SNAPSHOT 128
TABLE 107 EMA-APPROVED BIOSIMILARS 129
TABLE 108 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION) 132
TABLE 109 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 132
TABLE 110 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 133
TABLE 111 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 133
TABLE 112 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 134
TABLE 113 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 134
TABLE 114 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 134
TABLE 115 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 135
TABLE 116 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 135
TABLE 117 EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 135
10.3.1 GERMANY 136
10.3.1.1 Increasing R&D investments and initiatives to boost market growth 136
TABLE 118 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 136
TABLE 119 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 137
TABLE 120 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 137
TABLE 121 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 137
TABLE 122 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 138
TABLE 123 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 138
TABLE 124 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 138
TABLE 125 GERMANY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 139
10.3.2 UK 139
10.3.2.1 Favorable R&D scenario to boost software adoption 139
TABLE 126 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 140
TABLE 127 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 140
TABLE 128 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 141
TABLE 129 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 141
TABLE 130 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2015–2018 (USD MILLION) 141
TABLE 131 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE,
2019–2026 (USD MILLION) 142
TABLE 132 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 142
TABLE 133 UK: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 142
10.3.3 FRANCE 143
10.3.3.1 High number of oncology clinical trials to drive market growth 143
TABLE 134 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 143
TABLE 135 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 144
TABLE 136 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 144
TABLE 137 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 144
TABLE 138 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 145
TABLE 139 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 145
TABLE 140 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 145
TABLE 141 FRANCE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 146
10.3.4 ITALY 146
10.3.4.1 Low drug approval times drive growing adoption of eClinical solutions 146
TABLE 142 NUMBER OF CLINICAL TRIALS STARTED IN ITALY, BY COMPANY, 2017 146
TABLE 143 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 147
TABLE 144 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 147
TABLE 145 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 148
TABLE 146 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 148
TABLE 147 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 148
TABLE 148 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 149
TABLE 149 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 149
TABLE 150 ITALY: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 149
10.3.5 SPAIN 150
10.3.5.1 Rising R&D expenditure to propel market growth 150
TABLE 151 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 150
TABLE 152 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 151
TABLE 153 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 151
TABLE 154 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 151
TABLE 155 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 152
TABLE 156 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 152
TABLE 157 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018(USD MILLION) 152
TABLE 158 SPAIN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 153
10.3.6 REST OF EUROPE 153
TABLE 159 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION) 154
TABLE 160 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION) 154
TABLE 161 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION) 155
TABLE 162 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION) 155
TABLE 163 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 155
TABLE 164 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 156
TABLE 165 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018(USD MILLION) 156
TABLE 166 REST OF EUROPE: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION) 156
10.4 ASIA-PACIFIC 157
FIGURE 28 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SNAPSHOT 157
TABLE 167 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2015–2018 (USD MILLION) 159
TABLE 168 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY COUNTRY,
2019–2026 (USD MILLION) 159
TABLE 169 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 160
TABLE 170 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 160
TABLE 171 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION) 161
TABLE 172 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION) 161
TABLE 173 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 161
TABLE 174 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 162
TABLE 175 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 162
TABLE 176 ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 162
10.4.1 CHINA 163
10.4.1.1 Low cost of clinical trials and large pharmaceutical R&D base to drive market growth 163
TABLE 177 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 163
TABLE 178 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 164
TABLE 179 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 164
TABLE 180 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 164
TABLE 181 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 165
TABLE 182 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 165
TABLE 183 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 165
TABLE 184 CHINA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 166
10.4.2 JAPAN 166
10.4.2.1 Stringent regulatory scenario to restrain market growth 166
TABLE 185 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 166
TABLE 186 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 167
TABLE 187 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 167
TABLE 188 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 167
TABLE 189 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 168
TABLE 190 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 168
TABLE 191 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 168
TABLE 192 JAPAN: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 169
10.4.3 INDIA 169
10.4.3.1 Favorable pharmaceutical R&D scenario to drive software adoption 169
TABLE 193 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2015–2018 (USD MILLION) 170
TABLE 194 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT,
2019–2026 (USD MILLION) 170
TABLE 195 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2015–2018 (USD MILLION) 171
TABLE 196 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE,
2019–2026 (USD MILLION) 171
TABLE 197 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 171
TABLE 198 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 172
TABLE 199 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2015–2018 (USD MILLION) 172
TABLE 200 INDIA: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER,
2019–2026 (USD MILLION) 172
10.4.4 REST OF ASIA PACIFIC 173
TABLE 201 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION) 173
TABLE 202 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION) 173
TABLE 203 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION) 174
TABLE 204 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION) 174
TABLE 205 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 174
TABLE 206 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 175
TABLE 207 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION) 175
TABLE 208 REST OF ASIA-PACIFIC: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION) 175
10.5 REST OF THE WORLD 176
FIGURE 29 ROW: ECLINICAL SOLUTIONS MARKET SNAPSHOT 176
TABLE 209 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2015–2018 (USD MILLION) 177
TABLE 210 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY PRODUCT, 2019–2026 (USD MILLION) 178
TABLE 211 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2015–2018 (USD MILLION) 178
TABLE 212 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY DELIVERY MODE, 2019–2026 (USD MILLION) 178
TABLE 213 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2015–2018 (USD MILLION) 179
TABLE 214 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY CLINICAL TRIAL PHASE, 2019–2026 (USD MILLION) 179
TABLE 215 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2015–2018 (USD MILLION) 179
TABLE 216 REST OF THE WORLD: ECLINICAL SOLUTIONS MARKET SIZE, BY END USER, 2019–2026 (USD MILLION) 180
11 COMPETITIVE LANDSCAPE 181
11.1 INTRODUCTION 181
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 181
FIGURE 30 ECLINICAL SOLUTIONS MARKET: STRATEGIES ADOPTED 181
11.3 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS 182
FIGURE 31 KEY PLAYERS IN ECLINICAL SOLUTIONS MARKET 182
11.4 MARKET SHARE ANALYSIS 183
FIGURE 32 GLOBAL ECLINICAL SOLUTIONS MARKET SHARE, BY KEY PLAYER, 2020 183
11.5 COMPANY EVALUATION QUADRANT 183
11.5.1 STARS 184
11.5.2 EMERGING LEADERS 184
11.5.3 PERVASIVE PLAYERS 184
11.5.4 PARTICIPANTS 184
FIGURE 33 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT, 2020 185
11.6 ECLINICAL SOLUTIONS MARKET: SME EVALUATION 186
11.6.1 PROGRESSIVE COMPANIES 186
11.6.2 STARTING BLOCKS 186
11.6.3 RESPONSIVE COMPANIES 186
11.6.4 DYNAMIC COMPANIES 186
FIGURE 34 ECLINICAL SOLUTIONS MARKET: COMPANY EVALUATION QUADRANT FOR SMES, 2020 187
11.7 COMPETITIVE BENCHMARKING 188
11.7.1 COMPANY SERVICE FOOTPRINT (25 COMPANIES) 188
FIGURE 35 COMPANY PORTFOLIO FOOTPRINT: ECLINICAL SOLUTIONS MARKET 188
TABLE 217 COMPANY REGION FOOTPRINT (25 COMPANIES) 189
11.8 COMPETITIVE SITUATIONS AND TRENDS 190
11.8.1 PRODUCT/SERVICE LAUNCHES 190
TABLE 218 PRODUCT/SERVICE LAUNCHES (2018 TO 2021) 190
11.8.2 DEALS 191
TABLE 219 DEALS 191
TABLE 220 OTHER DEVELOPMENTS 194
12 COMPANY PROFILES 195
(Business Overview, Products & services Offered, Recent Developments, and Right to win)*
12.1 KEY PLAYERS 195
12.1.1 ORACLE CORPORATION. 195
TABLE 221 ORACLE CORPORATION: BUSINESS OVERVIEW 195
FIGURE 36 ORACLE CORPORATION: COMPANY SNAPSHOT (2020) 196
12.1.2 DASSAULT SYSTÈMES 199
TABLE 222 DASSAULT SYSTÈMES: BUSINESS OVERVIEW 199
FIGURE 37 DASSAULT SYSTÈMES: COMPANY SNAPSHOT (2020) 200
12.1.3 PAREXEL INTERNATIONAL CORPORATION 204
TABLE 223 PAREXEL INTERNATIONAL CORPORATION: BUSINESS OVERVIEW 204
12.1.4 BIOCLINICA, INC. (SUBSIDIARY OF CINVEN) 206
TABLE 224 BIOCLINICA : BUSINESS OVERVIEW 206
12.1.5 DATATRAK INTERNATIONAL, INC. 209
TABLE 225 DATATRAK INTERNATIONAL, INC: BUSINESS OVERVIEW 209
FIGURE 38 DATATRAK INTERNATIONAL, INC.: COMPANY SNAPSHOT (2020) 209
12.1.6 SIGNANT HEALTH (CRF HEALTH) 211
TABLE 226 SIGNANT HEALTH : BUSINESS OVERVIEW 211
12.1.7 ERT CLINICAL 213
TABLE 227 NELSON LABORATORIES: BUSINESS OVERVIEW 213
12.1.8 MAXISIT INC. 216
TABLE 228 MAXISIT INC.: BUSINESS OVERVIEW 216
12.2 OTHER PLAYERS 218
12.2.1 4G CLINICAL 218
12.2.2 ECLINICAL SOLUTIONS LLC 218
12.2.3 VEEVA SYSTEMS 219
12.2.4 RESEARCH MANAGER 219
12.2.5 SAAMA TECHNOLOGIES 220
12.2.6 MEDNET 220
12.2.7 ANJU SOFTWARE (PORTFOLIO COMPANY OF ABRY PARTNERS) 221
12.2.8 MEDRIO INC 221
12.2.9 CASTOR EDC 222
12.2.10 CLINPACE CLINICAL RESEARCH 222
12.2.11 IBM WATSON HEALTH 223
12.2.12 ARIS GLOBAL 223
12.2.13 QURETEC. LTD 224
12.2.14 OPENCLINICA 224
12.2.15 ADVARRA 225
12.2.16 REAL TIME SOFTWARE SOLUTIONS 226
12.2.17 YPRIME 226
*Details on Business Overview, Products & services Offered, Recent Developments, and Right to win might not be captured in case of unlisted companies.
13 APPENDIX 227
13.1 DISCUSSION GUIDE* 227
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 231
13.3 AVAILABLE CUSTOMIZATIONS 233
13.4 RELATED REPORTS 233
13.5 AUTHOR DETAILS 234
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポート
MarketsandMarkets 社の最新刊レポート
本レポートと同じKEY WORD(end user)の最新刊レポート
よくあるご質問MarketsandMarkets社はどのような調査会社ですか?マーケッツアンドマーケッツ(MarketsandMarkets)は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/09/06 10:26 144.24 円 160.68 円 192.83 円 |